News tagged with glaxosmithkline
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
US adviser on board of firm that sold anthrax drug
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
Medications
May 20, 2013 |
5 / 5 (1) |
0
India announces low-cost rotavirus vaccine (Update)
The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world.
Medications
May 14, 2013 |
5 / 5 (1) |
0
Elan enters $1B royalty deal with Theravance
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.
Medications
May 13, 2013 |
not rated yet |
0
Save the Children teams up with pharma giant GSK in Africa
International development charity Save the Children is linking up with British pharmaceutical giant GlaxoSmithKline in what both sides say is a unique collaboration to save children's lives in Africa.
Medications
May 10, 2013 |
not rated yet |
0
FDA approves once-a-day inhaler from Glaxo
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
Medications
May 10, 2013 |
not rated yet |
0
Drugmaker GSK posts slumping Q1 profits
British drugs firm GlaxoSmithKline on Wednesday said its first-quarter net profit tumbled by almost a third, with the group hit by falling sales and a poor economic climate.
Medications
Apr 24, 2013 |
not rated yet |
0
UK alleges GSK paid off competitors to delay drugs
Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.
Medications
Apr 19, 2013 |
not rated yet |
1
US panel backs inhaler drug for lung disease
A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.
Medications
Apr 17, 2013 |
not rated yet |
0
FDA reviewing heart risks of Glaxo diabetes pill
(AP)—The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia.
Medications
Apr 12, 2013 |
not rated yet |
0
Flu vaccine linked to narcolepsy in under 30s: study
A vaccine used in Sweden in the 2009-2010 "swine flu" pandemic is linked to a higher risk of the sleeping disorder narcolepsy among under 30s, and not just children and teens as previously thought, a Swedish study showed ...
Medications
Mar 26, 2013 |
5 / 5 (2) |
0
Study examines impact of minimally invasive surgery
(HealthDay)—For specific types of surgery, minimally invasive procedures correlate with significantly lower health plan spending and fewer days of absence from work, compared with standard surgery, according ...
Surgery
Mar 21, 2013 |
not rated yet |
0
Malaria vaccine fails to work after four years
A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.
Medications
Mar 20, 2013 |
1 / 5 (1) |
0
Anti-ageing drug breakthrough
Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The work, published in the March 8 issue of Science, finally proves that a single anti-ageing enzyme in the ...
Medical research
Mar 08, 2013 |
5 / 5 (10) |
2
New study validates longevity pathway: Findings identify universal mechanism for activating anti-aging pathway
A new study demonstrates what researchers consider conclusive evidence that the red wine compound resveratrol directly activates a protein that promotes health and longevity in animal models. What's more, the researchers ...
Medical research
Mar 07, 2013 |
4.8 / 5 (20) |
6
|
GlaxoSmithKline
GlaxoSmithKline plc (LSE: GSK NYSE: GSK) is a United Kingdom-based pharmaceutical, biological, and healthcare company. GSK is the world's second largest pharmaceutical company and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
For more information about GlaxoSmithKline, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
